Device Trial Radar · NCT06008457
Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
Last checked: Nov 19, 2026Latest source record: Jun 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,600
Actual
Start
Apr 17, 2023
Primary completion
May 31, 2025
Study completion May 31, 2025
Sponsor
- Lead sponsor
- Sequenom, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Labcorp Corporation of America Holdings, Inc
- First posted
- Aug 23, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 2 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV) and/or SARS-CoV-2 (C-19).
Conditions
- COVID-19 Respiratory Infection
- Influenza A
- Influenza Type B
- RSV Infection
Interventions
Labcorp COVID-19+Flu+RSV Test Home Collection KitDevice
The self-collected Labcorp COVID-19+Flu+RSV Test Home Collection Kit results as generated by the commercially available Labcorp Seasonal Respiratory Virus RT-PCR Test will be compared to the HCP-collected results as generated by Labcorp R\&D using the comparator assays.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Collection method comparisonTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Exer Urgent Care
Pasadena, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.